Hallucination induced by paroxetine discontinuation in patients with major depressive disordersYASUI-FURUKORI, Norio; KANEKO, Sunao.Psychiatry and clinical neurosciences (Carlton. Print). 2011, Vol 65, Num 4, pp 384-385, issn 1323-1316, 2 p.Article

Digitalis intoxication induced by paroxetine co-administrationYASUI-FURUKORI, Norio; KANEKO, Sunao.Lancet (British edition). 2006, Vol 367, Num 9512, pp 788-788, issn 0140-6736, 1 p.Article

Carbamazepine decreases antihypertensive effect of nilvadipineYASUI-FURUKORI, Norio; TATEISHI, Tomonori.Journal of clinical pharmacology. 2002, Vol 42, Num 1, pp 100-103, issn 0091-2700Article

Sensitive determination of midazolam and 1'-hydroxymidazolam in plasma by liquid-liquid extraction and column-switching liquid chromatography with ultraviolet absorbance detection and its application for measuring CYP3A activityYASUI-FURUKORI, Norio; INOUE, Yoshimasa; TATEISHI, Tomonori et al.Journal of chromatography. B. 2004, Vol 811, Num 2, pp 153-157, issn 1570-0232, 5 p.Article

Visual Hallucinations During Duloxetine Treatment in a Patient With Major Depressive DisorderTOMITA, Tetsu; YASUI-FURUKORI, Norio; KANEKO, Sunao et al.Clinical neuropharmacology. 2013, Vol 36, Num 5, pp 175-176, issn 0362-5664, 2 p.Article

Determination of a new atypical antipsychotic agent perospirone and its metabolite in human plasma by automated column-switching high-performance liquid chromatographyYASUI-FURUKORI, Norio; INOUE, Yoshimasa; TATEISHI, Tomonori et al.Journal of chromatography. B. 2003, Vol 789, Num 2, pp 239-245, issn 1570-0232, 7 p.Article

Determination of fluvoxamine and its metabolite fluvoxamino acid by liquid-liquid extraction and column-switching high-performance liquid chromatographyYASUI-FURUKORI, Norio; INOUE, Yoshimasa; KANEKO, Sunao et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 1, pp 121-125, issn 0731-7085, 5 p.Article

Neuroleptic Malignant Syndrome Induced by LamotrigineISHIOKA, Masamichi; YASUI-FURUKORI, Norio; HASHIMOTO, Kojiro et al.Clinical neuropharmacology. 2013, Vol 36, Num 4, pp 131-132, issn 0362-5664, 2 p.Article

Effective electroconvulsive therapy in a 92-year-old dementia patient with psychotic featureKATAGAI, Hiroshi; YASUI-FURUKORI, Norio; KIKUCHI, Atsuhiro et al.Psychiatry and clinical neurosciences (Carlton. Print). 2007, Vol 61, Num 5, pp 568-570, issn 1323-1316, 3 p.Article

Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detectionYASUI-FURUKORI, Norio; FURUYA, Rie; TAKAHATA, Takenori et al.Journal of chromatography. B, Biomedical sciences and applications. 2002, Vol 768, Num 2, pp 261-265, issn 1387-2273Article

Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokineticsYASUI-FURUKORI, Norio; UNO, Tsukasa; SUGAWARA, Kazunobu et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 1, pp 17-23, issn 0009-9236, 7 p.Article

Hydroxylation of R(+)- and S(―)-Omeprazole after Racemic Dosing are Different among the CYP2C19 GenotypesSHIOHIRA, Hideo; YASUI-FURUKORI, Norio; YAMADA, Satoshi et al.Pharmaceutical research. 2012, Vol 29, Num 8, pp 2310-2316, issn 0724-8741, 7 p.Article

Identification of predictors of post-ictal delirium after electroconvulsive therapyKIKUCHI, Atsuhiro; YASUI-FURUKORI, Norio; FUJII, Akira et al.Psychiatry and clinical neurosciences (Carlton. Print). 2009, Vol 63, Num 2, pp 180-185, issn 1323-1316, 6 p.Article

New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidoneSATO, Yasushi; YASUI-FURUKORI, Norio; KANEKO, Sunao et al.SATO, Yasushi; Progress in neuro-psychopharmacology & biological psychiatry. 2008, Vol 32, Num 2, pp 577-578, issn 0278-5846, 2 p.Article

Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patientsYASUI-FURUKORI, Norio; TSUCHIMINE, Shoko; SAITO, Manabu et al.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 6, pp 1230-1234, issn 0278-5846, 5 p.Article

Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype statusUNO, Tsukasa; SHIMIZU, Mikiko; YASUI-FURUKORI, Norio et al.British journal of clinical pharmacology. 2006, Vol 61, Num 3, pp 309-314, issn 0306-5251, 6 p.Article

Fexofenadine does not affect omeprazole pharmacokinetics: Both are putative P-glycoprotein substratesTAKAHATA, Takenori; YASUI-FURUKORI, Norio; YOSHIYA, Gen et al.Basic & clinical pharmacology & toxicology (Print). 2004, Vol 94, Num 5, pp 252-256, issn 1742-7835, 5 p.Article

Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassayYASUI-FURUKORI, Norio; FURUKORI, Hanako; SAITO, Manabu et al.Therapeutic drug monitoring. 2003, Vol 25, Num 6, pp 709-714, issn 0163-4356, 6 p.Article

Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patientsYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; MIHARA, Kazuo et al.Journal of clinical psychopharmacology. 2003, Vol 23, Num 5, pp 435-440, issn 0271-0749, 6 p.Article

Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomersAKAMINE, Yumiko; MIURA, Masatomo; YASUI-FURUKORI, Norio et al.British journal of clinical pharmacology. 2012, Vol 73, Num 3, pp 478-481, issn 0306-5251, 4 p.Article

Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patientsYASUI-FURUKORI, Norio; KANEDA, Ayako; SUGAWARA, Norio et al.Journal of psychopharmacology (Oxford). 2012, Vol 26, Num 6, pp 806-812, issn 0269-8811, 7 p.Article

The association between sunshine duration and paroxetine response time in patients with major depressive disorderTOMITA, Tetsu; YASUI-FURUKORI, Norio; NAKAGAMI, Taku et al.Journal of affective disorders. 2012, Vol 136, Num 3, pp 1067-1071, issn 0165-0327, 5 p.Article

Formulations of Valproate Alter Valproate Metabolism: A Single Oral Dose Kinetic StudyNAGAI, Goyo; ONO, Shingo; YASUI-FURUKORI, Norio et al.Therapeutic drug monitoring. 2009, Vol 31, Num 5, pp 592-596, issn 0163-4356, 5 p.Article

Rifampicin markedly decreases plasma concentration and hypnotic effect of brotizolamUJIIE, Yukihiro; FUKASAWA, Takashi; YASUI-FURUKORI, Norio et al.Therapeutic drug monitoring. 2006, Vol 28, Num 3, pp 299-302, issn 0163-4356, 4 p.Article

Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone : In vivo evidence of involvement of P-glycoprotein in risperidone dispositionNAKAGAMI, Taku; YASUI-FURUKORI, Norio; SAITO, Manabu et al.Clinical pharmacology and therapeutics. 2005, Vol 78, Num 1, pp 43-51, issn 0009-9236, 9 p.Article